Bajaj Healthcare Ltd - 539872 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Bajaj HealthCare informed about the upload of the audio recording for its Q1 FY27 earnings call. The call, held on July 21, 2026, discussed the financial performance for the quarter ended June 30, 2026, and the recording is now accessible on the company's website.
Jul 21 2026 18:56:59
Bajaj Healthcare Ltd - 539872 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Bajaj Healthcare reported Q1 FY27 revenue of Rs.165.6 cr, marking an 11.3% YoY increase, while profit after tax grew by 15.8% YoY to Rs.13.7 cr. The company also saw a 16.4% YoY rise in EBITDA to Rs.29.6 cr, with gross margin expanding to 48.3%.
Jul 20 2026 20:50:33
Bajaj Healthcare Ltd - 539872 - Compliances- Statement Of Deviation & Variation
Bajaj Healthcare confirmed no deviation in the utilization of proceeds from its preferential issue of convertible warrants for Q1 FY27. This confirms funds were used as disclosed, including Rs. 52.71 cr balance from warrant conversion.
Jul 20 2026 20:32:31
Bajaj Healthcare Ltd - 539872 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Bajaj HealthCare's monitoring agency confirmed nil deviation in the utilization of Rs. 204.97 crore raised through a preferential issue for the quarter ended June 30, 2026. Rs. 193.24 crore has been utilized, with the remaining Rs. 11.73 crore held in the monitoring bank account, confirming compliance with offer objectives.
Jul 20 2026 20:26:18
Bajaj Healthcare Ltd - 539872 - Board Meeting Outcome for Outcome Of The Board Meeting
Bajaj Healthcare approved Q1 FY27 financial results, reporting revenue of ₹165.63 crores (up 11.28% YoY) and net profit of ₹13.70 crores (up 15.75% YoY). The board also approved the continuation of Mr. Gopalakrishnan Kesavan as Non-Executive Independent Director.
Jul 20 2026 19:44:06
Bajaj Healthcare Ltd - 539872 - Board Meeting Intimation for Consideration Of Financial Results
Bajaj HealthCare's Board of Directors will meet on July 20, 2026, to consider and approve the un-audited financial results for the quarter ended June 30, 2026.
Jul 14 2026 12:49:00
Read More